Registration of securities issued in business combination transactions

STOCK BASED COMPENSATION

v3.23.3
STOCK BASED COMPENSATION
6 Months Ended 12 Months Ended
Jun. 30, 2023
Dec. 31, 2022
STOCK BASED COMPENSATION    
STOCK-BASED COMPENSATION

NOTE 13 - STOCK-BASED COMPENSATION

 

Equity Incentive Plans

 

In the first quarter of 2016, the Company adopted the 2016 Equity Incentive Plan. In the fourth quarter of 2018, the Company adopted the 2018 Equity Incentive Plan. In July 2021, the Company assumed the 2019 Equity Incentive Plan as part of the acquisition of UMBRLA. The following table contains information about the Company's equity incentive plans as of June 30, 2023:

 

 

 

Awards Reserved for Issuance

 

 

Awards Exercised

 

 

Awards Outstanding

 

 

Awards Available for Grant

 

 

 

 

 

 

 

 

 

 

 

 

 

 

2016 Equity Incentive Plan

 

 

497,776

 

 

 

-

 

 

 

248,888

 

 

 

248,888

 

2018 Equity Incentive Plan

 

 

17,364,171

 

 

 

4,022,133

 

 

 

6,754,353

 

 

 

6,587,685

 

2019 Equity Incentive Plan

 

 

24,062,129

 

 

 

34,884

 

 

 

14,027,519

 

 

 

9,999,726

 

 

Stock-Based Compensation Expense

 

The following table sets forth the total stock-based compensation expense resulting from stock options and restricted grants of common stock to employees, directors and non-employee consultants in the consolidated statement of operations which are included in selling, general and administrative expenses:

 

 

 

(in thousands, except for shares / options)

 

 

 

For the Three Months Ended

 

 

 

June 30, 2023

 

 

June 30, 2022

 

Type of Award

 

Number of  

Shares or 

Options 

Granted

 

 

Stock-Based  

Compensation 

Expense

 

 

Number of  

Shares or 

Options 

Granted

 

 

Stock-Based  

Compensation

Expense

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Stock Options

 

 

-

 

 

$ 89

 

 

 

400,000

 

 

$ 1,352

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Stock Grants:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Employees (Common Stock)

 

 

-

 

 

 

-

 

 

 

1,200,000

 

 

 

170

 

Directors (Common Stock)

 

 

-

 

 

 

-

 

 

 

259,796

 

 

 

29

 

Non-Employee Consultants (Common Stock)

 

 

79,997,091

 

 

 

1,553

 

 

 

725,000

 

 

 

129

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Total Stock-Based Compensation Expense

 

 

 

 

 

$ 1,642

 

 

 

 

 

 

$ 1,680

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(in thousands, except for shares / options)

 

 

 

For the Six Months Ended

 

 

 

June 30, 2023

 

 

June 30, 2022

 

Type of Award

 

Number of 

Shares or

Options

Granted

 

 

Stock-Based 

Compensation

Expense

 

 

Number of 

Shares or

Options

Granted

 

 

Stock-Based 

Compensation

Expense

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Stock Options

 

 

-

 

 

$ 187

 

 

 

400,000

 

 

$ 3,174

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Stock Grants:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Employees (Common Stock)

 

 

-

 

 

 

-

 

 

 

2,100,000

 

 

 

352

 

Directors (Common Stock)

 

 

-

 

 

 

-

 

 

 

943,128

 

 

 

213

 

Non-Employee Consultants (Common Stock)

 

 

96,178,321

 

 

 

1,910

 

 

 

725,000

 

 

 

129

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Total Stock-Based Compensation Expense

 

 

 

 

 

$ 2,097

 

 

 

 

 

 

$ 3,868

 

Stock Options

 

The following table summarizes the Company’s stock option activity and related information for the six months ended June 30, 2023:

 

 

 

Number of

 

 

Weighted-  

Average Exercise 

Price Per Share

 

 

Weighted-  

Average  

Remaining  

Contractual  

Life

 

Aggregate  

Intrinsic  

Value of 

In-the-Money  

Options

 

 

 

 

 

 

 

 

 

 

 

 

 

Options Outstanding as of January 1, 2023

 

 

52,821,099

 

 

$ 0.23

 

 

 

 

 

 

Forfeited

 

 

(31,695,340 )

 

$ 0.23

 

 

 

 

 

 

Options Outstanding as of June 30, 2023

 

 

21,125,759

 

 

$ 0.23

 

 

7.1 years

 

$ -

 

Options Exercisable as of June 30, 2023

 

 

15,931,299

 

 

$ 0.28

 

 

7.5 years

 

$ -

 

 

As of June 30, 2023, total unrecognized stock-based compensation was $0.21 million. Such costs are expected to be recognized over a weighted-average period of approximately 1.01 years. The Company recognizes compensation expense for stock option awards on a straight-line basis over the applicable service period of the award. The service period is generally the vesting period.

 

The Company does not have sufficient historical information to develop reasonable expectations about future exercise patterns and post-vesting employment termination behavior. Hence, the Company uses the “simplified method” described in Staff Accounting Bulletin 107 to estimate the expected term of share option grants. The expected stock price volatility assumption was determined by examining the historical volatilities for the Company’s common stock. The Company will continue to analyze the historical stock price volatility and expected term assumptions as more historical data for the Company’s common stock becomes available. The risk-free interest rate assumption is based on the U.S. treasury instruments whose term was consistent with the expected term of the Company’s stock options. The expected dividend assumption is based on the Company’s history and expectation of dividend payouts. The Company has never paid dividends on its common stock and does not anticipate paying dividends on its common stock in the foreseeable future. Accordingly, the Company has assumed no dividend yield for purposes of estimating the fair value of the Company stock-based compensation.

NOTE 15 – STOCK-BASED COMPENSATION

 

Equity Incentive Plans

 

In the first quarter of 2016, the Company adopted the 2016 Equity Incentive Plan. In the fourth quarter of 2018, the Company adopted the 2018 Equity Incentive Plan. In July 2021, the Company assumed the 2019 Equity Incentive Plan as part of the acquisition of UMBRLA. The following table contains information about both plans as of December 31, 2022:

 

 

 

Awards

Reserved

for Issuance

 

 

Awards

Exercised

 

 

Awards

Outstanding

 

 

Awards

Available

for Grant

 

 

 

 

 

 

 

 

 

 

 

 

 

 

2016 Equity Incentive Plan

 

 

999,906

 

 

 

 

 

 

499,953

 

 

 

499,953

 

2018 Equity Incentive Plan

 

 

29,920,933

 

 

 

4,022,133

 

 

 

13,326,509

 

 

 

12,572,291

 

2019 Equity Incentive Plan

 

 

61,109,696

 

 

 

34,884

 

 

 

37,617,531

 

 

 

23,457,281

 

 

Stock-Based Compensation Expense

 

The following table sets forth the total stock-based compensation expense resulting from stock options and restricted grants of common stock to employees, directors and non-employee consultants in the consolidated statement of operations which are included in selling, general and administrative expenses:

 

 

 

(in thousands, except for number of shares or options)

For the Year Ended

 

 

 

December 31, 2022

 

 

December 31, 2021

 

Type of Award

 

Number of

Shares or

Options

Granted

 

 

Stock-Based Compensation

 Expense

 

 

Number of

Shares or

Options

Granted

 

 

Stock-

Based

Compensation

Expense

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Stock Options

 

 

1,075,001

 

 

$ 3,659

 

 

 

89,930,019

 

 

$ 2,415

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Stock Grants:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Employees (Common Stock)

 

 

2,100,000

 

 

 

352

 

 

 

250,000

 

 

 

68

 

Directors (Common Stock)

 

 

943,128

 

 

 

213

 

 

 

1,917,837

 

 

 

495

 

Non–Employee Consultants (Common Stock)

 

 

16,906,230

 

 

 

695

 

 

 

4,556,603

 

 

 

1,079

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Total Stock–Based Compensation Expense

 

 

 

 

 

$ 4,919

 

 

 

 

 

 

$ 4,057

 

 

On March 10, 2022, the Company terminated the employment of Oren Schauble, the Company’s President. On March 13, 2022, the Company terminated the employment of Francis Knuettel II, the Company’s Chief Executive Officer. The Company entered into separation agreements with each of Mr. Knuettel and Mr. Schauble regarding the compensation to be granted to each of them regarding their separation from the Company. In addition, on March 17, 2022 the Company entered into a consulting agreement with Mr. Schauble pursuant to which he will continue to provide certain services to the Company through a future agreed upon date. The Company granted Mr. Schauble 910,623 restricted shares of the Company's Common Stock in four monthly installments.

 

On April 12, 2022, the Company and Mr. Knuettel agreed to terms on a separation agreement. The Company agreed to pay Mr. Knuettel 50% of his annual base salary and continue his medical benefits for a period of six months. Mr. Knuettel's unvested shares and options vested immediately. As part of this separation agreement, Mr. Knuettel resigned as a director of the Company in March 2022.

 

On April 14, 2022, the Company and Dallas Imbimbo, an advisor to the Company and a director of the Company, agreed to terms on a separation agreement. The Company agreed to vest 100% of Mr. Imbimbo's restricted common stock granted pursuant to the advisor agreement with Mr. Imbimbo. The Company agreed to vest 100% of the options to purchase shares of the Company's common stock granted as part Mr. Imbimbo's Independent Director Agreement. The Company will pay Mr. Imbimbo $0.08 million in cash compensation. As part of this separation agreement, Mr. Imbimbo resigned as a director of the Company and as an Advisor to the Company in April 2022.

During the year ended December 31, 2022, the Company issued 16,181,230 shares of common stock to Adnant, LLC as compensation for its services and recorded stock-based compensation expense of $1.57 million for such shares. See "Note 22 - Related Party Transactions" for further information.

 

Stock Options

 

The following table summarizes the Company’s stock option activity and related information for the years ended December 31, 2022 and 2021:

 

 

 

Number

of Shares

 

 

Weighted-

Average

Exercise

Price

Per Share

 

 

Weighted-

Average

Remaining Contractual

Life

 

Aggregate

Intrinsic

Value of In-

the-Money

Options

 

 

 

 

 

 

 

 

 

 

 

 

 

Options Outstanding as of December 31, 2020

 

 

17,492,830

 

 

$ 0.41

 

 

 

 

 

 

Granted

 

 

88,627,220

 

 

$ 0.23

 

 

 

 

 

 

Exercised

 

 

(3,910,805 )

 

$

 

 

 

 

 

 

Forfeited

 

 

(13,547,745 )

 

$ 0.15

 

 

 

 

 

 

Expired

 

 

(410,120 )

 

$ 0.41

 

 

 

 

 

 

Options Outstanding as of December 31, 2021

 

 

88,251,380

 

 

$ 0.20

 

 

 

 

 

 

Granted

 

 

1,075,001

 

 

$ 0.14

 

 

 

 

 

 

Exercised

 

 

(146,212 )

 

$ 0.07

 

 

 

 

 

 

Forfeited

 

 

(19,365,073 )

 

$ 0.13

 

 

 

 

 

 

Expired

 

 

(16,993,997 )

 

$ 0.17

 

 

 

 

 

 

Options Outstanding as of December 31, 2022

 

 

52,821,099

 

 

$ 0.23

 

 

7.9 years

 

$ 2,846

 

Options Exercisable as of December 31, 2022

 

 

36,825,119

 

 

$ 0.27

 

 

 7.6 years

 

$

 

 

The aggregate intrinsic value is calculated as the difference between the Company’s closing stock price of $0.01 on December 31, 2022 and the exercise price of options, multiplied by the number of options. As of December 31, 2022 and 2021, total unrecognized stock-based compensation was $1.08 million and $7.97 million, respectively, which are expected to be recognized over a weighted-average period of approximately 1.6 years and 1.6 years.

 

The Company recognizes compensation expense for stock option awards on a straight-line basis over the applicable service period of the award. The service period is generally the vesting period. The following weighted-average assumptions were used to calculate stock-based compensation:

 

 

 

Year Ended December 31,

 

 

 

2022

 

 

2021

 

Expected Term

 

5.2 years

 

 

5 years

 

Volatility

 

 

103.0 %

 

 

106.7 %

Risk-Free Interest Rate

 

 

0.9 %

 

 

0.8 %

Dividend Yield

 

 

0 %

 

 

0 %

 

The Company does not have sufficient historical information to develop reasonable expectations about future exercise patterns and post-vesting employment termination behavior. Hence, the Company uses the “simplified method” described in Staff Accounting Bulletin 107 to estimate the expected term of share option grants. The expected stock price volatility assumption was determined by examining the historical volatilities for the Company’s common stock. The Company will continue to analyze the historical stock price volatility and expected term assumptions as more historical data for the Company’s common stock becomes available. The risk-free interest rate assumption is based on the U.S. treasury instruments whose term was consistent with the expected term of the Company’s stock options. The expected dividend assumption is based on the Company’s history and expectation of dividend payouts. The Company has never paid dividends on its common stock and does not anticipate paying dividends on its common stock in the foreseeable future. Accordingly, the Company has assumed no dividend yield for purposes of estimating the fair value of the Company stock-based compensation.